Six Months Ended
|
||||||||
April 28,
2024
|
April 30,
2023
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
95,454
|
$
|
88,223
|
||||
Adjustments to reconcile net income to net cash
|
||||||||
provided by operating activities:
|
||||||||
Depreciation and amortization
|
41,487
|
39,085
|
||||||
Share-based compensation
|
6,499
|
3,830
|
||||||
Changes in operating assets, liabilities and other
|
(25,446
|
)
|
(21,461
|
)
|
||||
Net cash provided by operating activities
|
117,994
|
109,677
|
||||||
Cash flows from investing activities:
|
||||||||
Purchases of property, plant and equipment
|
(63,311
|
)
|
(57,728
|
)
|
||||
Purchases of available-for-sale debt securities
|
(16,551
|
)
|
(9,837
|
)
|
||||
Proceeds from maturities of available-for-sale debt securities
|
9,000
|
4,000
|
||||||
Government incentives
|
1,419
|
1,393
|
||||||
Other
|
(6
|
)
|
(88
|
)
|
||||
Net cash used in investing activities
|
(69,449
|
)
|
(62,260
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayments of debt
|
(2,844
|
)
|
(14,720
|
)
|
||||
Proceeds from share-based arrangements
|
1,055
|
730
|
||||||
Net settlements of restricted stock awards
|
(2,938
|
)
|
(1,252
|
)
|
||||
Net cash used in financing activities
|
(4,727
|
)
|
(15,242
|
)
|
||||
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
|
(3,839
|
)
|
15,621
|
|||||
Net increase in cash, cash equivalents, and restricted cash
|
39,979
|
47,796
|
||||||
Cash, cash equivalents, and restricted cash, beginning of period
|
501,867
|
322,409
|
||||||
Cash, cash equivalents, and restricted cash, end of period
|
$
|
541,846
|
$
|
370,205
|